The direct correlation between a company's financial performance and its stock price is well-documented. Poor earnings reports typically lead to a decrease in stock price, as they may indicate underlying issues within the company or a less favorable future outlook. Given that the news specifically mentions Syra Health's worse-than-expected Q4 results, it's reasonable to expect a negative short-term impact on SYRA's stock price.